title: Experience with aggressive therapy in three children with unresectable malignant liver tumors.
abstract: BACKGROUND
  Children with malignant liver tumors often present with unresectable disease but need not be considered incurable. The advent of effective chemotherapy makes aggressive management feasible, as our experience with three such patients demonstrates. Procedure and Results One child with an unresectable undifferentiated sarcoma of the liver and two others with unresectable primary hepatoblastoma and lung metastases were treated with initial chemotherapy, followed by aggressive surgical management. Treatment with chemotherapy followed by hepatectomy and liver transplantation (cadaveric or live donor) in two children has resulted in disease-free survivals of 79 and 38 months. The third patient is alive and well 24 months following chemotherapy and aggressive resection of the primary and 12 metastatic lesions.
  
  
  CONCLUSIONS
  Initial chemotherapy for unresectable liver tumors with or without metastases is supported by the review of the literature. Consideration of orthotopic liver transplantation (OLT) from cadaveric or living related donor is warranted when the malignancy is demonstrably chemosensitive, independent of initial staging. Aggressive resection of primary and metastatic disease may be called for in selected cases.
authors.affiliation: Department of Pediatrics, University of Alberta, Walter C. MacKenzie Health Sciences Center, Edmonton, Alberta, Canada.
authors.forename: N A
authors.initials: NA
authors.lastname: Dower
authors.forename: L J
authors.initials: LJ
authors.lastname: Smith
authors.forename: G
authors.initials: G
authors.lastname: Lees
authors.forename: N
authors.initials: N
authors.lastname: Kneteman
authors.forename: H
authors.initials: H
authors.lastname: Idikio
authors.forename: J
authors.initials: J
authors.lastname: Emond
authors.forename: P
authors.initials: P
authors.lastname: Rosenthal
mesh_terms: D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007223:Infant; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male